Page 2 - Clinical Evolution News Today

Dive into advanced data, ethical issues at free online event (NatalyaBurova/iStock via Getty Images Plus) The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues. In the face of increasingly complex data, pressures to get therapies to market as rapidly as possible, desire to decrease patient burden, COVID-19-created obstacles, and other challenges, clinical research profession...

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations. Several COVID-19 vaccines have been approved and administered to millions of people around the globe. Since the virus’s arrival, researchers also have been on the hunt for drugs that can effectively battle the disease in patients that receive a positive diagnosis. Berg, a company that uses proprietary artificial i...

FDA current COVID-19 updates, actions and advice As the vaccine goes into the arms of more people around the country, the US agency keeps on top of issues around the virus, offering resources and guidance. The phenomenon of "vaccine euphoria" has taken hold in the US, with patients receiving their first or second shots gleefully sharing images on Facebook, Instagram and other social media platforms. Still, because the virus is not over, the US Food and Drug Administr...

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials. Through this agreement, GSK is looking to improve its GMP cell processing network to advance its early stage pipeline and streamline technical transfer. “The move by a leading pharmac...

Saama, Oracle partner on integrated clinical trial technology Saama’s range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development. Saama Technologies is collaborating with Oracle to integrate Saama’s smart applications with the Oracle Health Sciences Clinical One platform. The collaboration is intended to enable pharmaceutical companies and their research partners to harness artifi...

Gilead, Merck to team up on potential HIV combo treatment The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients. Gilead Sciences and Merck have entered into an agreement to co-develop and co-commercialize long-acting treatments in HIV. The intended solutions will combine Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside r...

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90. IQVIA has announced its Orchestrated Customer Engagement (OCE) solution is now in use by 140 life-sciences companies located in 90 countries. The most recent to sign on, Laboratoires Thea, is an independent eye-care group in Europe. The company reports its clients are leveraging OCE to accelerate their global digital...

(ake1150sb/iStock via Getty Images Plus) A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring. Outsourcing-Pharma recently spoke with Stewart Whiting, chief technical officer of Current Health, about how the use of home health monitoring has evolved in the month leading up to the pandemic, its new Community by Current Health offering, and what the landscape might look ...

The DT Clinical Trial Digital Tracker Survey indicates many trial professionals often are hesitant to dive fully into digital technology integration. DT Consulting has released its inaugural Clinical Trial Digital Tracker Survey, designed to assess industry attitudes about digital adoption by global trial sites. According to the findings, many site professionals are reluctant to integrate digital tech into their process, citing factors like cost, complexity and selec...

Thermo Fisher Scientific expands DTP trial service offerings (ADragan/iStock via Getty Images Plus) The direct-to-patient service is designed to support trials and help to minimize trial length and costs, while boosting enrollment and participation rates. Thermo Fisher Scientific has expanded its direct-to-patient (DTP) service offerings. The range now includes clinical site-to-patient, pharmacy-to-patient, and depot-to-patient services, so that patients can receive ...